Correlation between diabetic nephropathy and diabetic retinopathy as a long term complications of diabetes mellitus

1 Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. New York (USA): McGraw Hill Education; 2018. Harrison’s Principles of Internal Medicine 20th ed. Alvin CP, Kevin DN, Carmella EM. Chapter No. 396 Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology; 2850. Search in Google Scholar

2 Saini DC, Kochar A, Poonia R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. 2021;69(11):3364-3368. Search in Google Scholar

3 Yang Z, Tan TE, Shao Y, Wong TY, Li X. Classification of diabetic retinopathy: Past, present and future. Front Endocrinol (Lausanne). 2022;13:1079217. Search in Google Scholar

4 Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741-760. Search in Google Scholar

5 Liu X, Zhou X, Song W, Zeng J, Niu X. The Diagnostic Value of Circulating VEGF in Diabetic Retinopathy in Asia: A Systematic Review and Meta-analysis. Ophthalmic Epidemiol. 2022:1-9. Search in Google Scholar

6 Raman R, Rani PK, Rachepalle SR, Gnaanamurthy P, Uthra S. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311–8. Search in Google Scholar

7 Li L, Yang K, Li C, Zhang H, Yu H, Chen K, et al. Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes. Front Immunol. 2022;13:943325. Search in Google Scholar

8 Sun XJ, Zhang GH, Guo CM, Zhou ZY, Niu YL, Wang L, et al. Associations between psycho-behavioral risk factors and diabetic retinopathy: NHANES (2005-2018). Front Public Health. 2022;10:966714. Search in Google Scholar

9 Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am. 2004;88:1001–36. Search in Google Scholar

10 Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248-260. Search in Google Scholar

11 Pastor-Fajardo MT, Fajardo-Giménez MT, Bosch-Giménez VM, Pastor-Rosado J. Changes from 1986 to 2018 in the prevalence of obesity and overweight, metabolic control and treatment in children with type 1 diabetes mellitus in a Mediterranean area of Southeast Spain. BMC Pediatr. 2022;22(1):274. Search in Google Scholar

12 UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. Br Med J.1998;317:720–726. Search in Google Scholar

13 Yang J, Liu Z. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy. Front Endocrinol (Lausanne). 2022;13:816400. Search in Google Scholar

14 Rando MM, Guthoff M, Tiwari V, Biscetti F. Editorial: Diagnosis, prevention and treatment in diabetic nephropathy. Front Endocrinol (Lausanne). 2022;13:1011665. Search in Google Scholar

15 Navarro J, Sanchez A, Ba Aqeel SH, Ye M, Rehman MZ, Wysocki J, Rademaker A, Molitch ME, Batlle D. Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy. Kidney Int Rep. 2022;7(12):2657-2667. Search in Google Scholar

16 Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor meta-analysis Cardio-Renal Trialists’ Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: Collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788-1801. Search in Google Scholar

17 Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322-1325. Search in Google Scholar

18 Klein R, Klein BEK, Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV. Ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28. Search in Google Scholar

19 Klein R, Klein BEK,Moss SE, et all.Retinopathy in young onset diabetic patients.Diabetes Care 1995;8:311-5. Search in Google Scholar

20 Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021;2021:1497449. Search in Google Scholar

21 Ehtewish H, Arredouani A, El-Agnaf O. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. Int J Mol Sci. 2022; 23(11):6144. Search in Google Scholar

22 Vilsbøll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simó R, et al. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes Obes Metab. 2018;20(4):889-897. Search in Google Scholar

23 Tan TE, Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne). 2023;13:1077669. Search in Google Scholar

24 Wang N, Wei L, Liu D, Zhang Q, Xia X, Ding L, et al. Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy. Front Endocrinol (Lausanne). 2022;13:867600. Search in Google Scholar

25 Dinesen S, Stokholm L, Subhi Y, Peto T, Savarimuthu TR, Andersen N, et al. Five-Year Incidence of Proliferative Diabetic Retinopathy and Associated Risk Factors in a Nationwide Cohort of 201 945 Danish Patients with Diabetes. Ophthalmol Sci. 2023;3(3):100291. Search in Google Scholar